Want to see HK:6855 full AI Analyst Report?
Total Valuation
Ascentage Pharma Group International has a market cap or net worth of HK$12.97B. The enterprise value is HK$12.63K.
Market CapHK$12.97B
Enterprise ValueHK$12.63K
Share Statistics
Ascentage Pharma Group International has 373,616,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding373,616,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ascentage Pharma Group International’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -33.25%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-33.25%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee675.44K
Profits Per Employee-1.49M
Employee Count828
Asset Turnover0.14
Inventory Turnover4.61
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International is ―. Ascentage Pharma Group International’s PEG ratio is -0.09.
PE Ratio―
PS Ratio29.89
PB Ratio12.61
Price to Fair Value12.61
Price to FCF-13.91
Price to Operating Cash Flow-7.77
PEG Ratio-0.09
Income Statement
In the last 12 months, Ascentage Pharma Group International had revenue of 559.26M and earned -1.21B in profits. Earnings per share was -3.40.
Revenue559.26M
Gross Profit427.35M
Operating Income-1.18B
Pretax Income-1.20B
Net Income-1.21B
EBITDA-1.10B
Earnings Per Share (EPS)-3.40
Cash Flow
In the last 12 months, operating cash flow was -1.38B and capital expenditures -19.47M, giving a free cash flow of -1.40B billion.
Operating Cash Flow-1.38B
Free Cash Flow-1.40B
Free Cash Flow per Share-3.75
Dividends & Yields
Ascentage Pharma Group International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-56.92%
50-Day Moving Average35.08
200-Day Moving Average44.96
Relative Strength Index (RSI)51.83
Average Volume (3m)2.91M
Important Dates
Ascentage Pharma Group International upcoming earnings date is Mar 31, 2027, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateMar 31, 2027
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International as a current ratio of 1.79, with Debt / Equity ratio of 376.46%
Current Ratio1.79
Quick Ratio1.77
Debt to Market Cap0.12
Net Debt to EBITDA0.45
Interest Coverage Ratio-22.42
Taxes
In the past 12 months, Ascentage Pharma Group International has paid 6.76M in taxes.
Income Tax6.76M
Effective Tax Rate>-0.01
Enterprise Valuation
Ascentage Pharma Group International EV to EBITDA ratio is -14.79, with an EV/FCF ratio of -13.50.
EV to Sales29.01
EV to EBITDA-14.79
EV to Free Cash Flow-13.50
EV to Operating Cash Flow-13.82
Balance Sheet
Ascentage Pharma Group International has HK$1.90B in cash and marketable securities with HK$2.09B in debt, giving a net cash position of -HK$198.95M billion.
Cash & Marketable SecuritiesHK$1.90B
Total DebtHK$2.09B
Net Cash-HK$198.95M
Net Cash Per Share-HK$0.53
Tangible Book Value Per ShareHK$3.49
Margins
Gross margin is 81.56%, with operating margin of -211.14%, and net profit margin of -216.47%.
Gross Margin81.56%
Operating Margin-211.14%
Pretax Margin-215.29%
Net Profit Margin-216.47%
EBITDA Margin-196.08%
EBIT Margin-211.14%
Analyst Forecast
The average price target for Ascentage Pharma Group International is HK$44.37, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$44.37
Price Target Upside-12.84% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast70.26%
EPS Growth Forecast-12.79%